Gilead Sciences (GILD) News Today → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free GILD Stock Alerts $65.42 +0.15 (+0.23%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineGilead Sciences, Inc. Declares Quarterly Dividend of $0.77 (NASDAQ:GILD)marketbeat.com - April 27 at 11:15 AMGilead Sciences Q1 Earnings Transcriptmarketbeat.com - April 27 at 7:05 AMGilead Sciences (NASDAQ:GILD) Sets New 52-Week Low at $65.61americanbankingnews.com - April 27 at 5:32 AMGilead Sciences (NASDAQ:GILD) Upgraded at StockNews.comamericanbankingnews.com - April 27 at 2:18 AMTruist Financial Reaffirms Their Hold Rating on Gilead Sciences (GILD)markets.businessinsider.com - April 26 at 10:36 PMBank Julius Baer & Co. Ltd Zurich Has $34.83 Million Stake in Gilead Sciences, Inc. (NASDAQ:GILD)marketbeat.com - April 26 at 8:17 PMMorgan Stanley Lowers Gilead Sciences (NASDAQ:GILD) Price Target to $78.00marketbeat.com - April 26 at 2:28 PMGilead Sciences Says FDA OK's Updated Label Of Biktarvy To Treat Pregnant People With HIV-1markets.businessinsider.com - April 26 at 12:34 PMGilead Gives Up Big Gains As Covid Drug Drives Its Beat — Againfinance.yahoo.com - April 26 at 12:34 PMGilead Sciences (NASDAQ:GILD) Receives "Hold" Rating from Needham & Company LLCmarketbeat.com - April 26 at 8:43 AMGilead: Q1 Earnings Snapshotwashingtonpost.com - April 26 at 7:34 AMGilead Sciences Inc (GILD) Q1 2024 Earnings Call Transcript Highlights: Key Financials and ...finance.yahoo.com - April 26 at 7:34 AMZacks Research Research Analysts Lower Earnings Estimates for Gilead Sciences, Inc. (NASDAQ:GILD)americanbankingnews.com - April 26 at 1:38 AMDow Inc. Q1 Earnings Summarymarkets.businessinsider.com - April 25 at 9:33 PMGilead’s quarterly loss is narrower than expectedmsn.com - April 25 at 9:33 PMGilead Sciences, Inc. 2024 Q1 - Results - Earnings Call Presentationseekingalpha.com - April 25 at 8:14 PMGILD Stock Earnings: Gilead Sciences Beats EPS, Beats Revenue for Q1 2024investorplace.com - April 25 at 8:11 PMGilead Sciences (NASDAQ:GILD) Releases Earnings Results, Beats Expectations By $0.17 EPSmarketbeat.com - April 25 at 7:01 PMGilead Beats Earnings Expectations After Rocky Quarterbarrons.com - April 25 at 5:49 PMGilead Sciences (NASDAQ:GILD) Updates FY 2024 Earnings Guidancemarketbeat.com - April 25 at 5:47 PMGilead Sciences Inc (GILD) Q1 2024 Earnings: Misses Analyst EPS Estimates Amid Significant ...gurufocus.com - April 25 at 5:04 PMGilead posts quarterly loss, revenue rises 5%reuters.com - April 25 at 4:11 PMGilead Sciences Announces First Quarter 2024 Financial Resultsbusinesswire.com - April 25 at 4:02 PMGilead Sciences (NASDAQ:GILD) Reaches New 12-Month Low at $65.61marketbeat.com - April 25 at 3:45 PMGilead Sciences Target of Unusually Large Options Trading (NASDAQ:GILD)marketbeat.com - April 25 at 1:11 PMAlaska Permanent Fund Corp Sells 25,031 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)marketbeat.com - April 25 at 10:02 AMQ1 2024 EPS Estimates for Gilead Sciences, Inc. (NASDAQ:GILD) Decreased by Analystmarketbeat.com - April 25 at 7:37 AMGilead Sciences (NASDAQ:GILD) Upgraded to "Hold" at HSBCamericanbankingnews.com - April 25 at 6:15 AMFY2024 EPS Estimates for Gilead Sciences, Inc. Decreased by Analyst (NASDAQ:GILD)americanbankingnews.com - April 25 at 4:02 AMGilead Sciences, Inc. (NASDAQ:GILD) Forecasted to Post Q2 2024 Earnings of $1.40 Per Shareamericanbankingnews.com - April 25 at 2:30 AMBailard Inc. Sells 48,838 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)marketbeat.com - April 24 at 11:39 PMGilead Sciences Q1 Preview: HIV pipeline, FY24 guidance in focusmsn.com - April 24 at 6:37 PMHSBC Upgrades Gilead Sciences (NASDAQ:GILD) to "Hold"marketbeat.com - April 24 at 1:57 PMFY2024 EPS Estimates for Gilead Sciences, Inc. Reduced by Cantor Fitzgerald (NASDAQ:GILD)marketbeat.com - April 24 at 6:32 AMGilead Q1 Earnings Preview: Most Gains Wiped Out - Cause For Concern?seekingalpha.com - April 23 at 11:02 AMSigma Planning Corp Sells 22,684 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)marketbeat.com - April 23 at 6:49 AMIllinois Municipal Retirement Fund Sells 79,102 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)marketbeat.com - April 22 at 10:22 PMUndervalued Icons: 3 Household Names Trading at Steep Discountsinvestorplace.com - April 22 at 2:19 PMGilead Sciences: Some Signs Of An Impending Bottomseekingalpha.com - April 22 at 2:12 PMFoundry Partners LLC Decreases Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)marketbeat.com - April 21 at 10:35 PMGilead Sciences (NASDAQ:GILD) Stock Rating Reaffirmed by Oppenheimeramericanbankingnews.com - April 21 at 5:22 AMGilead Sciences (NASDAQ:GILD) Stock Rating Lowered by StockNews.comamericanbankingnews.com - April 21 at 1:34 AMabrdn plc Raises Position in Gilead Sciences, Inc. (NASDAQ:GILD)marketbeat.com - April 20 at 12:10 PMFDA Mandates "Boxed Warning" For Bristol Myers, Johnson & Johnson CAR-T-Based Blood Cancer Therapiesmsn.com - April 20 at 2:23 AMGilead Sciences (NASDAQ:GILD) Rating Lowered to Buy at StockNews.commarketbeat.com - April 19 at 11:04 PMXponance Inc. Increases Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)marketbeat.com - April 19 at 10:17 AMGilead Sciences (NASDAQ:GILD) Sets New 52-Week Low on Analyst Downgradeamericanbankingnews.com - April 19 at 5:36 AMGilead Sciences (NASDAQ:GILD) PT Lowered to $75.00americanbankingnews.com - April 19 at 2:36 AMGilead Sciences Publishes 2023 ESG Impact Reportfinance.yahoo.com - April 18 at 5:59 PMHold Rating on Gilead Sciences Amidst Q1 Revenue Shortfall and Acquisition Concernsmarkets.businessinsider.com - April 18 at 12:59 PM Get Gilead Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for GILD and its competitors with MarketBeat's FREE daily newsletter. Email Address The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet. See how you can invest alongside him GILD Media Mentions By Week GILD Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GILD News Sentiment▼0.220.32▲Average Medical News Sentiment GILD News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GILD Articles This Week▼6116▲GILD Articles Average Week Get Gilead Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for GILD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: SGEN News Today BIIB News Today AMGN News Today MRNA News Today ARGX News Today HCA News Today GSK News Today ZTS News Today BMY News Today REGN News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GILD) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingProtect Your Bank Account Before It’s Too LateWeiss RatingsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThey say it’s ‘unstoppable’ – How I made 43,509% Investing DailyBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gilead Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
